Targeting the Gatekeeper MET146 of C-Jun N-Terminal Kinase 3 Induces a Bivalent Halogen/Chalcogen Bond.
暂无分享,去创建一个
Pierre Koch | Andreas Lange | Susanne Hennig | Adrian Sievers-Engler | Francesco Ansideri | Thilo Stehle | Stefan Zahn | Markus O Zimmermann | Frank M Boeckler | S. Laufer | T. Stehle | F. Boeckler | M. Zimmermann | Andreas Lange | P. Koch | S. Zahn | Marcel Günther | Stefan A Laufer | Susanne Hennig | Michael Laemmerhofer | Felix Michael Büttner | Johannes Heidrich | Christoph Schall | F. Ansideri | J. Heidrich | Adrian Sievers-Engler | F. M. Büttner | Marcel Günther | Michael Laemmerhofer | Christopher Schall | Stefan Zahn
[1] P. Caron,et al. Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. , 1998, Structure.
[2] O. Ottoni,et al. EFFICIENT AND SIMPLE METHODS FOR THE INTRODUCTION OF THE SULFONYL, ACYL AND ALKYL PROTECTING GROUPS ON THE NITROGEN OF INDOLE AND ITS DERIVATIVES , 1998 .
[3] Martin Lepšík,et al. Quantum mechanical scoring: structural and energetic insights into cyclin-dependent kinase 2 inhibition by pyrazolo[1,5-a]pyrimidines. , 2013, Current computer-aided drug design.
[4] Thomas E. Exner,et al. Data quality in drug discovery: the role of analytical performance in ligand binding assays , 2015, Journal of Computer-Aided Molecular Design.
[5] Pierangelo Metrangolo,et al. Definition of the halogen bond (IUPAC Recommendations 2013) , 2013 .
[6] Markus O. Zimmermann,et al. Using halogen bonds to address the protein backbone: a systematic evaluation , 2012, Journal of Computer-Aided Molecular Design.
[7] Anton Simeonov,et al. Fluorescence polarization assays in small molecule screening , 2011, Expert opinion on drug discovery.
[8] S. Laufer,et al. c-Jun N-terminal kinase inhibitors: a patent review (2010 – 2014) , 2015, Expert opinion on therapeutic patents.
[9] Wolfgang Albrecht,et al. Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. , 2012, Nature chemical biology.
[10] Markus O. Zimmermann,et al. Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53 , 2012, Journal of the American Chemical Society.
[11] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[12] Yu Zhang,et al. Chalcogen bond: a sister noncovalent bond to halogen bond. , 2009, The journal of physical chemistry. A.
[13] Peter Politzer,et al. An overview of halogen bonding , 2007, Journal of molecular modeling.
[14] Martin Lepšík,et al. Modulation of aldose reductase inhibition by halogen bond tuning. , 2013, ACS chemical biology.
[15] Pierre Koch,et al. Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery. , 2014, Future medicinal chemistry.
[16] Timothy Clark,et al. Halogen bonding and other σ-hole interactions: a perspective. , 2013, Physical chemistry chemical physics : PCCP.
[17] György G. Ferenczy,et al. Enthalpic Efficiency of Ligand Binding , 2010, J. Chem. Inf. Model..
[18] A. Joerger,et al. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. , 2013, Journal of medicinal chemistry.
[19] Horst Köppel,et al. Theoretical investigations on chalcogen-chalcogen interactions: what makes these nonbonded interactions bonding? , 2006, Journal of the American Chemical Society.
[20] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[21] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[22] B. Beno,et al. A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design. , 2015, Journal of medicinal chemistry.
[23] Richard J. Marhöfer,et al. Molecular Graphics - Trends and Perspectives , 2000 .
[24] François Diederich,et al. Systematic investigation of halogen bonding in protein-ligand interactions. , 2011, Angewandte Chemie.
[25] J. Murray,et al. Simultaneous σ-hole and hydrogen bonding by sulfur- and selenium-containing heterocycles , 2008 .
[26] T. Ceska,et al. Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors. , 2007, Bioorganic & medicinal chemistry letters.
[27] M. Prudhomme,et al. Synthesis of aminopyrimidylindoles structurally related to meridianins , 2007 .
[28] Jindřich Fanfrlík,et al. Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine , 2011, Journal of molecular modeling.
[29] Michael S. Cohen,et al. Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors , 2005, Science.
[30] Barbara Kirchner,et al. Addressing Methionine in Molecular Design through Directed Sulfur-Halogen Bonds. , 2011, Journal of chemical theory and computation.
[31] J. Murray,et al. σ-hole bonding: molecules containing group VI atoms , 2007 .
[32] Britt-Marie Swahn,et al. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3. , 2005, Bioorganic & medicinal chemistry letters.
[33] Eric Westhof,et al. Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Lisnock,et al. The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity. , 2003, Chemistry & biology.
[35] Markus O. Zimmermann,et al. Targeting Histidine Side Chains in Molecular Design through Nitrogen-Halogen Bonds , 2013, J. Chem. Inf. Model..
[36] Pierre Koch,et al. Inhibitors of c-Jun N-terminal kinases: an update. , 2015, Journal of medicinal chemistry.
[37] Michal Otyepka,et al. Semiempirical quantum mechanical method PM6-DH2X describes the geometry and energetics of CK2-inhibitor complexes involving halogen bonds well, while the empirical potential fails. , 2011, The journal of physical chemistry. B.
[38] C. Peifer,et al. Fluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinase. , 2010, Analytical biochemistry.
[39] Xueliang Fang,et al. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. , 2004, Analytical biochemistry.
[40] Markus O. Zimmermann,et al. Evaluating the Potential of Halogen Bonding in Molecular Design: Automated Scaffold Decoration Using the New Scoring Function XBScore , 2015, J. Chem. Inf. Model..
[41] P. Molina,et al. Synthesis and cytotoxic evaluation of new derivatives of the marine alkaloid variolin B. , 2006, Journal of medicinal chemistry.